Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
methionine adenosyltransferase 2A | 0.615 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
microfibril associated protein 5 | 0.590 | 0.615 | 5.1E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
protein kinase cGMP-dependent 1 | 0.603 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
forkhead box E3 | 0.568 | 0.654 | 0.18 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
NSE2 (MMS21) homolog, SMC5-SMC6 complex SUMO ligase | 0.682 | 0.615 | 3.8E-02 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ETS homologous factor | 0.650 | 0.577 | 0.71 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
purinergic receptor P2Y12 | 0.533 | 0.731 | 1.7E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
nitric oxide synthase 2 | 0.364 | 0.923 | 4.0E-15 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
actin alpha 2, smooth muscle | 0.508 | 0.846 | 0.93 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
myosin heavy chain 11 | 0.528 | 0.731 | 0.77 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
SMAD family member 3 | 0.415 | 0.923 | 0.80 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
myosin light chain kinase | 0.510 | 0.846 | 9.2E-12 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2001 | 2001 | ||||||||
|
ANKRD44 intronic transcript 1 | 0.821 | 0.192 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
ankyrin repeat domain 44 | 0.780 | 0.269 | 0.34 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
dymeclin | 0.563 | 0.769 | 3.6E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
G protein subunit gamma 2 | 0.821 | 0.346 | 0.51 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
peptidylprolyl isomerase A | 0.510 | 0.769 | 0.56 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
cathepsin A | 0.619 | 0.731 | 5.9E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
arginine vasopressin | 0.437 | 0.846 | 7.4E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2015 | 2015 | ||||||||
|
interleukin 17D | 0.464 | 0.808 | 0.20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ocular albinism 3 (autosomal recessive) | 0.890 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |